Superior treatment persistence with ustekinumab in Crohn’s disease and vedolizumab in ulcerative colitis compared with anti‐TNF biological agents: real‐world registry data from the Persistence Australian National IBD Cohort (PANIC) study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Superior treatment persistence with ustekinumab in Crohn’s disease and vedolizumab in ulcerative colitis compared with anti‐TNF biological agents: real‐world registry data from the Persistence Australian National IBD Cohort (PANIC) study
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 54, Issue 3, Pages 292-301
Publisher
Wiley
Online
2021-06-21
DOI
10.1111/apt.16436
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn’s Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States
- (2020) Camilo Obando et al. ADVANCES IN THERAPY
- Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or Ustekinumab
- (2020) Anne Hu et al. Clinical Gastroenterology and Hepatology
- Big data in IBD: a look into the future
- (2019) Pablo Olivera et al. Nature Reviews Gastroenterology & Hepatology
- Safety of drugs used for the treatment of Crohn’s disease
- (2019) Aviv Pudipeddi et al. Expert Opinion On Drug Safety
- Ustekinumab for Crohn’s disease: a nationwide real-life cohort study from Finland (FINUSTE)
- (2019) Anja Eberl et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
- (2019) Nicholas A Kennedy et al. Lancet Gastroenterology & Hepatology
- Impact of immunomodulator use on treatment persistence in patients with ulcerative colitis: A claims database analysis
- (2019) Taku Kobayashi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Persistence with Biologic Treatment in Patients with Inflammatory Bowel Disease: A German Claims Data Analysis
- (2019) Antje Mevius et al. DIGESTION
- Infliximab, Azathioprine, or Infliximab + Azathioprine for Treatment of Moderate to Severe Ulcerative Colitis: The UC Success Trial
- (2018) Remo Panccione et al. GASTROENTEROLOGY
- Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
- (2018) Pei-Tzu Lin et al. Scientific Reports
- Treatment Persistence for Infliximab Versus Adalimumab in Crohnʼs Disease
- (2017) Pablo Olivera et al. INFLAMMATORY BOWEL DISEASES
- Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD
- (2017) Laura E. Targownik et al. INFLAMMATORY BOWEL DISEASES
- A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population
- (2017) Graeme Jones et al. International Journal of Rheumatic Diseases
- Review article: acute severe ulcerative colitis - evidence-based consensus statements
- (2016) J.-H. Chen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biologic agents for IBD: practical insights
- (2015) Silvio Danese et al. Nature Reviews Gastroenterology & Hepatology
- Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitis
- (2014) Rupert W.L. Leong et al. Journal of Crohns & Colitis
- Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: A real life cohort study
- (2014) Christopher Ma et al. Journal of Crohns & Colitis
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population
- (2012) Christina Ha et al. Clinical Gastroenterology and Hepatology
- Medication Compliance and Persistence: Terminology and Definitions
- (2007) Joyce A. Cramer et al. VALUE IN HEALTH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started